ClinicalTrials.Veeva

Menu

Respiratory Muscle Strength in Patients With NMD (RMST)

University of Florida logo

University of Florida

Status

Terminated

Conditions

Neuromuscular Disease

Treatments

Device: Threshold PEP or IMT device Phillips-Respironics

Study type

Interventional

Funder types

Other

Identifiers

NCT01555905
IRB201600270

Details and patient eligibility

About

The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.

Full description

Subjects undergo a 12-week period of inspiratory muscle strength training. Respiratory strength is assessed before and after the training period.

Enrollment

17 patients

Sex

All

Ages

6 months to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed diagnosis of neuromuscular disease
  • Clinical evidence of impaired pulmonary function

Exclusion criteria

  • Above or below age range
  • No clinical evidence of impaired pulmonary function
  • No diagnosis of a neuromusuclar disease
  • Presence of an acute illness at time of study
  • Participating in other research studies involving investigational drugs
  • Diagnosis of a primary pulmonary disease
  • Use of tobacco products

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

17 participants in 1 patient group

Exercise
Experimental group
Description:
Threshold PEP or IMT device Phillips-Respironics
Treatment:
Device: Threshold PEP or IMT device Phillips-Respironics

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems